159 related articles for article (PubMed ID: 18446462)
1. Optimization studies on design and evaluation of orodispersible pediatric formulation of indomethacin.
Singh J; Philip AK; Pathak K
AAPS PharmSciTech; 2008; 9(1):60-6. PubMed ID: 18446462
[TBL] [Abstract][Full Text] [Related]
2. Modified polysaccharides as fast disintegrating excipients for orodispersible tablets of roxithromycin.
Sharma V; Philip AK; Pathak K
AAPS PharmSciTech; 2008; 9(1):87-94. PubMed ID: 18446466
[TBL] [Abstract][Full Text] [Related]
3. Formulation and optimization of orodispersible tablets of diazepam.
Abed KK; Hussein AA; Ghareeb MM; Abdulrasool AA
AAPS PharmSciTech; 2010 Mar; 11(1):356-61. PubMed ID: 20232267
[TBL] [Abstract][Full Text] [Related]
4. Formulation and evaluation of Cetirizine dihydrochloride orodispersible tablet.
Subramanian S; Sankar V; Manakadan AA; Ismail S; Andhuvan G
Pak J Pharm Sci; 2010 Apr; 23(2):232-5. PubMed ID: 20363705
[TBL] [Abstract][Full Text] [Related]
5. Formulation Design and Optimization of Orodispersible Tablets of Quetiapine Fumarate by Sublimation Method.
Kalyankar P; Panzade P; Lahoti S
Indian J Pharm Sci; 2015; 77(3):267-73. PubMed ID: 26180271
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of two novel co-processed excipients for direct compression of orodispersible tablets and mini-tablets.
Kokott M; Lura A; Breitkreutz J; Wiedey R
Eur J Pharm Biopharm; 2021 Nov; 168():122-130. PubMed ID: 34474110
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Disintegrant-addition Methods on the Compounding of Orodispersible Tablets.
Mahesparan VA; Bin Abd Razak FS; Ming LC; Uddin AH; Sarker MZI; Bin LK
Int J Pharm Compd; 2020; 24(2):148-155. PubMed ID: 32196477
[TBL] [Abstract][Full Text] [Related]
8. Formulation, Optimization and
Ejeta F; Gabriel T; Joseph NM; Belete A
Curr Drug Deliv; 2022; 19(1):129-141. PubMed ID: 34126894
[TBL] [Abstract][Full Text] [Related]
9. Formulation, in vitro characterization and optimization of taste-masked orally disintegrating co-trimoxazole tablet by direct compression.
Tafere C; Yilma Z; Abrha S; Yehualaw A
PLoS One; 2021; 16(3):e0246648. PubMed ID: 33725014
[TBL] [Abstract][Full Text] [Related]
10. Preparation and Optimization of Fast-Disintegrating Tablet Containing Naratriptan Hydrochloride Using D-Optimal Mixture Design.
Omar SM; AbdAlla FI; Abdelgawad NM
AAPS PharmSciTech; 2018 Aug; 19(6):2472-2487. PubMed ID: 29869307
[TBL] [Abstract][Full Text] [Related]
11. The effects of screw configuration and polymeric carriers on hot-melt extruded taste-masked formulations incorporated into orally disintegrating tablets.
Morott JT; Pimparade M; Park JB; Worley CP; Majumdar S; Lian Z; Pinto E; Bi Y; Durig T; Repka MA
J Pharm Sci; 2015 Jan; 104(1):124-34. PubMed ID: 25410968
[TBL] [Abstract][Full Text] [Related]
12. Amorphous Formulation and in Vitro Performance Testing of Instantly Disintegrating Buccal Tablets for the Emergency Delivery of Naloxone.
Alqurshi A; Kumar Z; McDonald R; Strang J; Buanz A; Ahmed S; Allen E; Cameron P; Rickard JA; Sandhu V; Holt C; Stansfield R; Taylor D; Forbes B; Royall PG
Mol Pharm; 2016 May; 13(5):1688-98. PubMed ID: 26977787
[TBL] [Abstract][Full Text] [Related]
13. Locust bean gum as superdisintegrant--formulation and evaluation of nimesulide orodispersible tablets.
Malik K; Arora G; Singh I
Polim Med; 2011; 41(1):17-28. PubMed ID: 21739929
[TBL] [Abstract][Full Text] [Related]
14. Orodispersible tablets containing taste-masked solid lipid pellets with metformin hydrochloride: Influence of process parameters on tablet properties.
Petrovick GF; Kleinebudde P; Breitkreutz J
Eur J Pharm Biopharm; 2018 Jan; 122():137-145. PubMed ID: 29106946
[TBL] [Abstract][Full Text] [Related]
15. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
Sano S; Iwao Y; Kimura S; Itai S
Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
[TBL] [Abstract][Full Text] [Related]
16. A methodological evaluation and predictive in silico investigation into the multi-functionality of arginine in directly compressed tablets.
ElShaer A; Kaialy W; Akhtar N; Iyire A; Hussain T; Alany R; Mohammed AR
Eur J Pharm Biopharm; 2015 Oct; 96():272-81. PubMed ID: 26255158
[TBL] [Abstract][Full Text] [Related]
17. Design, development and in-vitro evaluation of diclofenac taste-masked orodispersible tablet formulations.
Guhmann M; Preis M; Gerber F; Pöllinger N; Breitkreutz J; Weitschies W
Drug Dev Ind Pharm; 2015 Apr; 41(4):540-51. PubMed ID: 24495274
[TBL] [Abstract][Full Text] [Related]
18. Formulation and evaluation of taste-masked levocetirizine dihydrochloride orally disintegrating tablets.
Devireddy SR; Gonugunta CS; Veerareddy PR
PDA J Pharm Sci Technol; 2009; 63(6):521-6. PubMed ID: 20169858
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of different approaches for preparation of chlorzoxazone orodispersible tablets.
Moqbel HA; ElMeshad AN; El-Nabarawi MA
Drug Dev Ind Pharm; 2017 May; 43(5):742-750. PubMed ID: 27534668
[TBL] [Abstract][Full Text] [Related]
20. Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion.
Sammour OA; Hammad MA; Megrab NA; Zidan AS
AAPS PharmSciTech; 2006 Jun; 7(2):E55. PubMed ID: 16796372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
